Article
Development of a Robust Mammalian Cell-based Assay for Studying Recombinant α4 β1/3 δ GABAA Receptor Subtypes.
Basic & clinical pharmacology & toxicology - 1 Aug 2017
Falk-Petersen Christina B, Søgaard Rikke, Madsen Kenneth L, Klein Anders B, Frølund Bente, Wellendorph Petrine
Abstract excerpt
δ-Containing GABAA receptors are located extrasynaptically and mediate tonic inhibition. Their involvement in brain physiology positions them as interesting drug targets. There is thus a continued interest in establishing reliable recombinant expression systems for δ-containing GABAA receptors. Inconveniently, the recombinant expression of especially α4 β1/3 δ receptors has been found to be notoriously difficult,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
